& x20;When is the reason to perform a naloxone challenge test on the client with opioid abuse? - NORCET 1 - 2020

NORCET 1 - 2020

Pharmacology

Easy

Appeared in: NORCET 1 - 2020

Explanation

The naloxone challenge test is a diagnostic procedure used to determine if a patient is physically dependent on opioids.
It is a critical safety measure performed before initiating treatment with an opioid antagonist like naltrexone to avoid precipitating a severe, acute withdrawal syndrome.
Naloxone is an opioid antagonist that, when administered in a small dose, will displace opioids from their receptors.
If the patient is physically dependent, this displacement triggers observable withdrawal symptoms (e.g., sweating, yawning, muscle aches), confirming the state of dependence.

Option A: This option is too vague. The test is not checking for a general drug reaction but for the very specific reaction of opioid withdrawal, which is a sign of physical dependence.
Option B: The test is a physiological assessment of the body's dependence on a substance. It has no capacity to measure a patient's psychological state, motivation, or 'interest' in treatment.
Option C: The naloxone challenge test is a diagnostic tool, not a therapeutic one. While naloxone is used to treat acute opioid overdose, the 'challenge test' itself is for assessment, not treatment of the underlying abuse disorder.

Visual 1: Flowchart: Illustrating the clinical pathway for starting naltrexone treatment, showing the naloxone challenge test as a critical safety checkpoint after an initial opioid-free period.
Visual 2: Infographic: Comparing the signs of opioid intoxication (e.g., pinpoint pupils, respiratory depression) versus the signs of naloxone-precipitated withdrawal (e.g., dilated pupils, yawning, sweating, muscle aches).

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Purpose and indication of the naloxone challenge test as background academic context rather than a clinical decision trigger.
Patient Safety: Performing this test is a critical safety measure to prevent iatrogenic acute withdrawal syndrome, which is extremely distressing and can be medically dangerous for the patient.
Accurate Assessment: It provides an objective measure of physical dependence, guiding the clinician in making safe and appropriate treatment decisions for opioid use disorder.
What if the patient has a positive naloxone challenge test? The nurse must not administer naltrexone. The patient requires a longer opioid-free period for detoxification before the test can be safely repeated. The healthcare provider must be notified immediately of the positive test result.

How to Approach the Question

First, identify the keywords in the question: 'reason to perform' and 'naloxone challenge test'. This indicates you need to know the specific purpose of this diagnostic test.
Recognize that a 'challenge test' in medicine is typically done to provoke a reaction to confirm or rule out a condition.
Evaluate the options based on this understanding. Option C ('treat') is unlikely, as a 'challenge' is usually diagnostic, not therapeutic.
Consider the pharmacology of naloxone: it is an opioid antagonist. An antagonist's primary effect in a dependent person is to block opioid effects and precipitate withdrawal.
Compare the remaining options. 'Check patient interest' (Option B) is a psychological assessment, not a pharmacological one. 'Check the reaction of the drug' (Option A) is too general.
Conclude that 'check the level of physical dependence' (Option D) is the most precise and accurate reason, as precipitating withdrawal is the direct method of assessing physical dependence.

Concept Tested & Keywords

QY5lp0XiamPEWh5n8I4TmC